Technology | Flat Panel Displays | March 03, 2016

NEC MultiSync MD211G5 Display Receives FDA Clearance for Tomosynthesis

Five-megapixel grayscale monitor also cleared for standard, full field digital mammography

NEC Displays, FDA clearance, MultiSync MD211G5, tomosynthesis, FFDM

March 3, 2016 — NEC Display Solutions of America announced U.S. Food and Drug Administration clearance of its MultiSync MD211G5 medical-grade monitor for use in tomosynthesis applications and full field digital mammography (FFDM). The 21-inch NEC display is built for the displaying and viewing of digital images for diagnosis by trained physicians.

The 5-megapixel grayscale monitor, which also has been cleared for standard mammography, offers out-of-the-box factory DICOM calibration and uniformity control for consistent imaging across the entire screen. Its IPS panel features a 1200:1 contrast ratio and 500 cd/m2 of calibrated brightness. The MD211G5 display also comes with GammaCompMD QA software for managing conformance to the AAPM TG-18 standard.

Digital breast tomosynthesis (DBT), which combines tomography with digital radiography, renders breast images in 3-D and accounts for more than one-half of the breast-imaging market, according to a report by iData Research.

A separate study by the University of Pennsylvania’s Perelman School of Medicine published in JAMA Oncology found that initial DBT screening led to, among other things, fewer patients called back for sometimes unnecessary imaging.

For more information: www.necdisplay.com

Related Content

Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
The COVID-19 pandemic has impacted every facet of personal life, business operations and healthcare, including breast imaging and breast cancer care.

Getty Images

Feature | Breast Imaging | September 18, 2020 | By Susan Harvey, M.D.
The COVID-19 pandemic has impacted every facet o
UT Dallas study aims to advance thermography for monitoring tumors

Adolfo Lozano, PhD'20, works on a proof-of-concept computer model of the thermal properties of breast cancer. He and other UT Dallas researchers aim to improve digital thermal imaging as a tool for monitoring cancer and its treatment. Image courtesy of The University of Texas at Dallas

News | Breast Imaging | September 09, 2020
September 9, 2020 — ...
The solution leverages image transfer speed, tag morphing, and multi-vendor PACS capabilities to enable comprehensive image visualization and analysis at the point of care
News | Breast Imaging | September 03, 2020
September 3, 2020 — Based on its recent analysis of the global breast imaging workstation industry, Frost & Sulli